000			01633 a2200469 4500
005			20250513233922.0
264		0	_c20010419
008			200104s 0 0 eng d
022			_a0098-7484
024	7		_a10.1001/jama.285.12.1585 _2doi
040			_aNLM _beng _cNLM
100	1		_aRobins, S J
245	0	0	_aRelation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. _h[electronic resource]
260			_bJAMA _cMar 2001
300			_a1585-91 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
650	0	4	_aCholesterol, HDL _xblood
650	0	4	_aCholesterol, LDL _xblood
650	0	4	_aCoronary Disease _xblood
650	0	4	_aDouble-Blind Method
650	0	4	_aGemfibrozil _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aHypolipidemic Agents _xtherapeutic use
650	0	4	_aLipids _xblood
650	0	4	_aMale
650	0	4	_aMultivariate Analysis
650	0	4	_aMyocardial Infarction
650	0	4	_aProportional Hazards Models
650	0	4	_aSurvival Analysis
700	1		_aCollins, D
700	1		_aWittes, J T
700	1		_aPapademetriou, V
700	1		_aDeedwania, P C
700	1		_aSchaefer, E J
700	1		_aMcNamara, J R
700	1		_aKashyap, M L
700	1		_aHershman, J M
700	1		_aWexler, L F
700	1		_aRubins, H B
773	0		_tJAMA _gvol. 285 _gno. 12 _gp. 1585-91
856	4	0	_uhttps://doi.org/10.1001/jama.285.12.1585 _zAvailable from publisher's website
999			_c11204440 _d11204440